What does PHARMATHUS do?

PHARMATHUS is a pharmacy in Aubange. Private Limited, started on 26 December 1997, 1 establishment.

What is the address of PHARMATHUS?

The registered office of PHARMATHUS is located at Rue du Commerce - ATHUS 19 D, 6791 Aubange.

Is PHARMATHUS still active?

Yes. According to the CBE (30 October 2026) PHARMATHUS is active, legal situation “Normale toestand”, started on 26 December 1997.

Is PHARMATHUS registered on Peppol?

Yes, PHARMATHUS is registered on the Peppol network with ID 0208:0462268940.

What is the enterprise number of PHARMATHUS?

The enterprise number of PHARMATHUS is BE0462268940.

When was PHARMATHUS founded?

PHARMATHUS was founded on 26 December 1997.

Who are the directors of PHARMATHUS?

According to the 2025 annual accounts, the directors of PHARMATHUS are: DSTM Holding SRL.

Is PHARMATHUS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 December 1997; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMATHUS make in 2025?

PHARMATHUS posted a profit after taxes of € 209,797 in financial year 2025.

What is the revenue of PHARMATHUS?

As a small company, PHARMATHUS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 612,062.

How much does an employee at PHARMATHUS earn?

The average wage cost per full-time employee at PHARMATHUS was € 49,900 in 2025: staff costs of € 269,220 for 5.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMATHUS have?

According to the 2025 annual accounts, PHARMATHUS has 5.4 full-time equivalents (FTE).

Does PHARMATHUS have a website?

Yes, PHARMATHUS has a website at pharmathus.com.

PHARMATHUS (Private Limited) - Aubange - BE0462268940

Dossier PHARMATHUS, printed on 30 October 2026 from databakkes.be/en/0462268940/pharmathus. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 46 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMATHUS from Aubange, company number BE0462268940, closed financial year 2025 with a result of € 209,797 after tax. For that financial year PHARMATHUS recorded a gross margin of € 612,062 and equity of € 261,016. Compared with financial year 2024, the result moved from € 152,666 to € 209,797. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What it is worth Growing

€ 261,016

▲ 24% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 209,797

▲ 37% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 48,040

▼ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 160,000 paid out

76 % of the profit went to the shareholders, mostly to DSTM HOLDING (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

5.4

▲ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 269,220

▼ 11% vs 2024

€ 49,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,580

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 217,390

▼ 2% vs 2024

€ 83,348 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 132,944

▲ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 74,045

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 513,661 Gross margin 2022: € 513,661 First fiscal year in the series	€ 496,968 Gross margin 2023: € 496,968 ▼ 3% vs 2022 (€ 513,661) Unfavourable step	€ 569,915 Gross margin 2024: € 569,915 ▲ 15% vs 2023 (€ 496,968) Favourable step	€ 612,062 Gross margin 2025: € 612,062 ▲ 7% vs 2024 (€ 569,915) Favourable step	▲ 7%
Profit after taxes	€ 196,269 Profit after taxes 2022: € 196,269 First fiscal year in the series	€ 162,558 Profit after taxes 2023: € 162,558 ▼ 17% vs 2022 (€ 196,269) Unfavourable step	€ 152,666 Profit after taxes 2024: € 152,666 ▼ 6% vs 2023 (€ 162,558) Unfavourable step	€ 209,797 Profit after taxes 2025: € 209,797 ▲ 37% vs 2024 (€ 152,666) Favourable step	▲ 37%
Equity	€ 195,994 Equity 2022: € 195,994 First fiscal year in the series	€ 203,552 Equity 2023: € 203,552 ▲ 4% vs 2022 (€ 195,994) Favourable step	€ 211,218 Equity 2024: € 211,218 ▲ 4% vs 2023 (€ 203,552) Favourable step	€ 261,016 Equity 2025: € 261,016 ▲ 24% vs 2024 (€ 211,218) Favourable step	▲ 24%
Total debts	€ 644,980 Total debts 2022: € 644,980 First fiscal year in the series	€ 582,920 Total debts 2023: € 582,920 ▼ 10% vs 2022 (€ 644,980) Favourable step	€ 567,665 Total debts 2024: € 567,665 ▼ 3% vs 2023 (€ 582,920) Favourable step	€ 584,903 Total debts 2025: € 584,903 ▲ 3% vs 2024 (€ 567,665) Unfavourable step	▲ 3%
Cash	€ 65,203 Cash 2022: € 65,203 First fiscal year in the series	€ 52,945 Cash 2023: € 52,945 ▼ 19% vs 2022 (€ 65,203) Unfavourable step	€ 53,496 Cash 2024: € 53,496 ▲ 1% vs 2023 (€ 52,945) Favourable step	€ 48,040 Cash 2025: € 48,040 ▼ 10% vs 2024 (€ 53,496) Unfavourable step	▼ 10%
Retained profit	€ 177,402 Retained profit 2022: € 177,402 First fiscal year in the series	€ 184,960 Retained profit 2023: € 184,960 ▲ 4% vs 2022 (€ 177,402) Favourable step	€ 192,626 Retained profit 2024: € 192,626 ▲ 4% vs 2023 (€ 184,960) Favourable step	€ 242,424 Retained profit 2025: € 242,424 ▲ 26% vs 2024 (€ 192,626) Favourable step	▲ 26%
Dividend	€ 165,000 Dividend 2022: € 165,000 First fiscal year in the series	€ 155,000 Dividend 2023: € 155,000 ▼ 6% vs 2022 (€ 165,000) Unchanged	€ 145,000 Dividend 2024: € 145,000 ▼ 6% vs 2023 (€ 155,000) Unchanged	€ 160,000 Dividend 2025: € 160,000 ▲ 10% vs 2024 (€ 145,000) Unchanged	▲ 10%
Bank debt	€ 358,873 Bank debt 2022: € 358,873 First fiscal year in the series	€ 279,143 Bank debt 2023: € 279,143 ▼ 22% vs 2022 (€ 358,873) Favourable step	€ 221,149 Bank debt 2024: € 221,149 ▼ 21% vs 2023 (€ 279,143) Favourable step	€ 217,390 Bank debt 2025: € 217,390 ▼ 2% vs 2024 (€ 221,149) Favourable step	▼ 2%
Balance sheet total	€ 840,974 Balance sheet total 2022: € 840,974 First fiscal year in the series	€ 786,473 Balance sheet total 2023: € 786,473 ▼ 6% vs 2022 (€ 840,974) Unchanged	€ 778,884 Balance sheet total 2024: € 778,884 ▼ 1% vs 2023 (€ 786,473) Unchanged	€ 845,919 Balance sheet total 2025: € 845,919 ▲ 9% vs 2024 (€ 778,884) Unchanged	▲ 9%
Employees (FTE)	3.9 Employees (FTE) 2022: 3.9 First fiscal year in the series	4 Employees (FTE) 2023: 4 ▲ 0.1 vs 2022 (3.9) Unchanged	5 Employees (FTE) 2024: 5 ▲ 1 vs 2023 (4) Unchanged	5.4 Employees (FTE) 2025: 5.4 ▲ 0.4 vs 2024 (5) Unchanged	▲ 0.4

Key figures of PHARMATHUS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMATHUS?

What happened at PHARMATHUS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 24, 2026 New annual accounts for financial year 2025: profit of € 209,797 (▲ 37% vs 2024). Source: NBB ↗
2016 DSTM Holding SRL became a director. NBB
Mar 3, 1998 New establishment in Aubange. KBO
Dec 26, 1997 Start of the company according to the CBE. KBO

In short

From € 196,269 profit in 2022 to € 209,797 profit in 2025.

Paid € 187,574 in corporate taxes since 2022.

Best year ever: 2025, with € 209,797 profit.

On average € 113,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

DSTM HOLDING 100%

The stake of DSTM HOLDING comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMATHUS

Behind PHARMATHUS is DSTM Holding SRL. The shares are held by DSTM HOLDING (100%).

Directors

According to the 2025 annual accounts

DSTM Holding SRL

Manager · represented by Johanne SIVA

Also active at: MT Pharma

since 2016

Shareholders

DSTM HOLDING

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Commerce - ATHUS 19 D

6791 Aubange

2.122.671.388

Grand-rue - ATHUS 24 2

6791 Aubange

Active since 3 March 1998

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmathus.com

Technologies

AWS S3ApacheBackbone.jsGoogle FontsLightboxPHPPWAWordPressjQueryjQuery UI

Hosting & Email

Email provider

Self-hosted

Hosting

HETZNER-AS, DE

Domain

pharmathus.com

Registered

2016-06-22

Registrar

Infomaniak Network SA

Expires

2026-06-22

Website info

HTTPS Ja

Languages FR

Features

Blog Client portal Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0462.268.940

VAT number

BE 0462.268.940

Registered office

Rue du Commerce - ATHUS 19 D, 6791 Aubange

Names & denominations

PHARMATHUS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 December 1997

Peppol

Active · Active since 4 Nov 2025

Contact

pharmathus.com

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMATHUS

Warning lights

Financials

What happened to PHARMATHUS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions